Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges

@article{Pai2015InnovationsIT,
  title={Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges},
  author={M. Pai},
  journal={EBioMedicine},
  year={2015},
  volume={2},
  pages={182 - 183}
}
  • M. Pai
  • Published 2015
  • Medicine
  • EBioMedicine
  • Despite the long and hard battle against tuberculosis (TB), WHO estimated that 9 million people developed the disease in 2013, and nearly 1.5 million people died of TB (World Health Organization, 2014). To make matters worse, drug-resistance is a growing threat, and 3 out of 9 million TB cases are either not diagnosed, or not notified to TB control programs. But there is some good news from the perspective of new tool introduction. Slowly but surely, the landscape of TB technologies is… CONTINUE READING

    Tables and Topics from this paper.

    Integrating exosomal microRNAs and electronic health data improved tuberculosis diagnosis
    9

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 10 REFERENCES
    Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.
    130
    Defining the needs for next generation assays for tuberculosis.
    74
    Target product profile of a molecular drug-susceptibility test for use in microscopy centers.
    28
    Biomarkers and diagnostics for tuberculosis
    4
    Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
    433
    Molecular drug susceptibility testing — defining assay characteristics for the use at the level of the microscopy center
    • 2015